FT
MRNA icon

Fiduciary Trust’s Moderna MRNA Stock Holding History

Fiduciary Trust’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-162,974
Closed -$4.5M – 865
2025
Q2 		$4.5M Buy
162,974
+559
+0.3% +$14.7K 0.06% 182
2025
Q1 		$4.6M Buy
162,415
+423
+0.3% +$15K 0.06% 181
2024
Q4 		$6.74M Buy
161,992
+9
+0% +$430 0.09% 136
2024
Q3 		$10.8M Sell
161,983
-1,062
-0.7% -$97.5K 0.15% 100
2024
Q2 		$19.4M Sell
163,045
-56,000
-26% -$7.09M 0.29% 60
2024
Q1 		$23.3M Sell
219,045
-288
-0.1% -$29K 0.36% 54
2023
Q4 		$21.8M Sell
219,333
-15
-0% -$1.26K 0.36% 51
2023
Q3 		$22.7M Buy
219,348
+268
+0.1% +$29.9K 0.41% 46
2023
Q2 		$26.6M Sell
219,080
-17
-0% -$2.27K 0.47% 44
2023
Q1 		$33.6M Hold
219,097
– – 0.62% 32
2022
Q4 		$39.4M Sell
219,097
-52,983
-19% -$8.66M 0.77% 24
2022
Q3 		$32.2M Buy
272,080
+6
+0% +$910 0.7% 27
2022
Q2 		$38.9M Buy
272,074
+145
+0.1% +$20.7K 0.82% 23
2022
Q1 		$46.8M Hold
271,929
– – 0.84% 21
2021
Q4 		$69.1M Sell
271,929
-700
-0.3% -$205K 1.14% 14
2021
Q3 		$105M Buy
272,629
+271,297
+20,368% +$100M 1.87% 8
2021
Q2 		$313K Sell
1,332
-599,988
-100% -$107M 0.01% 547
2021
Q1 		$78.7M Sell
601,320
-499,931
-45% -$72.4M 1.6% 9
2020
Q4 		$115M Sell
1,101,251
-821,723
-43% -$83.1M 2.4% 6
2020
Q3 		$136M Hold
1,922,974
– – 3.21% 6
2020
Q2 		$123M Sell
1,922,974
-299,900
-13% -$16.4M 3.06% 6
2020
Q1 		$66.6M Sell
2,222,874
-1,040,094
-32% -$23.9M 1.93% 8
2019
Q4 		$63.8M Sell
3,262,968
-400,000
-11% -$7.1M 1.49% 10
2019
Q3 		$58.3M Sell
3,662,968
-610,000
-14% -$9.01M 1.46% 11
2019
Q2 		$62.6M Sell
4,272,968
-38,958
-0.9% -$837K 1.64% 10
2019
Q1 		$87.7M Sell
4,311,926
-1
-0% -$19 2.36% 8
2018
Q4 		$65.8M Buy
+4,311,927
New +$70.9M 2.02% 9

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fiduciary Trust's MRNA Position: Q3 2025 in Review

Fiduciary Trust sold out of Moderna (MRNA) in Q3 2025, closing a stake of 162,974 shares — an estimated $4.5M sold.

Fiduciary Trust first reported a position in MRNA in Q4 2018 and held it in 27 quarters. The position peaked at $136M in Q3 2020. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Fiduciary Trust reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • Fiduciary Trust sold 162,974 Moderna shares in Q3 2025, an estimated $4.5M.
  • Fiduciary Trust first reported a position in Moderna in Q4 2018 and held it in 27 quarters.
  • Fiduciary Trust's Moderna position peaked at $136M in Q3 2020.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Fiduciary Trust's 13F filing for Q3 2025, filed 14 Nov 2025.